Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
845 Leser
Artikel bewerten:
(2)

Bioservo signs distribution agreement with G-Hoo in South Korea

STOCKHOLM, Oct. 28, 2020 /PRNewswire/ -- Bioservo Technologies AB has signed a distribution agreement with G-Hoo Corporation Inc for selling Ironhand in South Korea.

G-HOO has during the last 20 years played a pivotal role in the Korean automotive industry as well as in general industries. They are focusing on improving their customers production processes by developing and implementing robotics systems based on industrial robots. When developing robotic systems, they take care of the entire process from installing, test-driving, and teaching to overhauling industrial robots. With their technical capacity and reliability, they are acknowledged in Korea and overseas. They are constantly striving to develop new techniques through their own technology research center.

"G-Hoo are experienced in providing leading edge solutions for both the automotive and other industries and we are pleased that they now will include Ironhand into their portfolio. South Korea is an interesting market with large companies within our focused industry segments, and this is in line with our efforts to strengthen our presence in Asia.", Says Petter Bäckgren, CEO at Bioservo.

About Bioservo Technologies

Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient.

The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength.

Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB, +46(0)8 528 00399, info@fnca.se is the Company's Certified Adviser on Nasdaq First North Growth Market.

For more information, please visit www.bioservo.com

For more information, please contact

Petter Bäckgren
CEO of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10
petter.backgren@bioservo.com

Mikael Wester
Marketing Director of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10
mikael.wester@bioservo.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioservo-technologies-ab--publ-/r/bioservo-signs-distribution-agreement-with-g-hoo-in-south-korea,c3226947

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.